US 10526285
Therapeutic compounds and methods of use thereof
granted A61PA61P1/02A61P1/04
Quick answer
US patent 10526285 (Therapeutic compounds and methods of use thereof) held by Xenon Pharmaceuticals Inc. expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Xenon Pharmaceuticals Inc.
- Grant date
- Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P1/02, A61P1/04, A61P11/00, A61P13/10